UCLA study: COVID vaccinations may lessen severe kidney damage
June 13 (UPI) -- A new study from UCLA Health suggests COVID vaccines may protect patients from severe kidney damage. The study found hospitalized COVID patients were less likely to have severe kidney damage if they were vaccinated.
UCLA Health researchers found 16% of unvaccinated patients were more likely to need a constant dialysis therapy, compared with 11% of vaccinated patients.
The study data came from roughly 3,500 patients admitted to hospitals between March 2020 and March 2022.
Study lead author and UCLA nephrology professor Dr. Niloofar Nobakht said the continuous renal replacement therapy (CRRT) form of dialysis is vital for intensive care patients with damaged kidneys.
The goal of the study was to asses the severity of kidney injury in COVID patients needing CRRT while hospitalized.
According to University of Pennsylvania biostatistics professor Yong Chen, serious kidney complications are typically associated with severe COVID cases.
Study participants had received at least two doses of the Pfizer or Moderna mRNA vaccines or one dose of the Johnson & Johnson Janssen vaccine.
Yale University Dr. F. Perry Wilson said the main reason vaccinated people have lower kidney injury rates is the vaccines tend to lessen the chances of severe illness.
He said the vaccines don't act directly on the kidneys but instead reduce overall illness severity, which in turn helps to prevent complications such as multi-organ failure.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Richton Park nursing home must pay $5.5 million in wrongful death lawsuit
More than four years after 85-year-old Sandy Brooks died under the care of Landmark of Richton Park Rehabilitation and Nursing Center, his family received news that a jury awarded them $5.5 million in a wrongful death lawsuit brought on his behalf. Brooks was an honest, hardworking husband, father and grandfather who wore his heart on his sleeve, said his daughter Andrea Brooks, 59. Though he had end-stage renal disease that required he receive dialysis three times per week, Andrea said Brooks was generally healthy and lived independently with his wife, Barbara, until he experienced a traumatic fall in October 2020 while watering plants outdoors at their South Side home. Brooks faced intensive treatment for a brain bleed at Advocate Christ Medical Center and made progress before being transferred to Landmark for physical therapy Nov. 25, Andrea Brooks said. 'We were expecting him to come home, because (doctors) were like, 'oh, he just needs therapy, and then from there he should be OK,'' Brooks said. Although COVID-19 era lockdowns remained in effect, Andrea Brooks said family members were able to regularly visit her dad at the hospital. That changed when he was admitted to Landmark, where he stayed for 13 days before he died after, according to the lawsuit, caregivers neglected to give him his required dialysis. 'We were not able to have any phone calls, there was no communication,' Brooks said. 'Nobody was updating us on anything.' Sandy's wife, Barbara, contacted the nursing home up to 10 times per day, rarely receiving responses, Andrea said. On Dec. 6, the family was allowed a brief FaceTime call with Sandy, who was unable to speak, she said, and he was found unresponsive in his room the next day. Sandy missed five dialysis appointments while under the care of Landmark, his family would later discover, prompting their lawsuit that concluded May 30. 'It appears that they were providing him some very basic care,' the family's attorney, Madison Cogan, said Friday. 'And by that, I mean they were going into his room, as far as we can tell. But as far as getting dialysis, that never happened, and I think that is what makes this so egregious. All it took is one nurse to recognize that Sandy needed his dialysis and that he wasn't receiving it.' A jury agreed, holding Landmark and its management company, Infinity Healthcare Management of Illinois LLC, accountable for $5.5 million in damages for neglecting Brooks, whose need for dialysis was chronicled by the hospital where he was previously treated. Landmark of Richton Park did not return messages requesting comment. Cogan said the family had sought between $6 million and $8 million. 'It's really hard to put a number on a life,' she said. Andrea said nothing has been the same since she lost her dad. 'This case, it made me relive everything,' she said. 'I could not believe the magnitude of how my dad suffered, and it just hurt me. It broke my heart that someone could just not care or not do their job.' ostevens@
Chicago Tribune
35 minutes ago
- Chicago Tribune
Richton Park nursing home must pay $5.5 million in wrongful death lawsuit
More than four years after 85-year-old Sandy Brooks died under the care of Landmark of Richton Park Rehabilitation and Nursing Center, his family received news that a jury awarded them $5.5 million in a wrongful death lawsuit brought on his behalf. Brooks was an honest, hardworking husband, father and grandfather who wore his heart on his sleeve, said his daughter Andrea Brooks, 59. Though he had end-stage renal disease that required he receive dialysis three times per week, Andrea said Brooks was generally healthy and lived independently with his wife, Barbara, until he experienced a traumatic fall in October 2020 while watering plants outdoors at their South Side home. Brooks faced intensive treatment for a brain bleed at Advocate Christ Medical Center and made progress before being transferred to Landmark for physical therapy Nov. 25, Andrea Brooks said. 'We were expecting him to come home, because (doctors) were like, 'oh, he just needs therapy, and then from there he should be OK,'' Brooks said. Although COVID-19 era lockdowns remained in effect, Andrea Brooks said family members were able to regularly visit her dad at the hospital. That changed when he was admitted to Landmark, where he stayed for 13 days before he died after, according to the lawsuit, caregivers neglected to give him his required dialysis. 'We were not able to have any phone calls, there was no communication,' Brooks said. 'Nobody was updating us on anything.' Sandy's wife, Barbara, contacted the nursing home up to 10 times per day, rarely receiving responses, Andrea said. On Dec. 6, the family was allowed a brief FaceTime call with Sandy, who was unable to speak, she said, and he was found unresponsive in his room the next day. Sandy missed five dialysis appointments while under the care of Landmark, his family would later discover, prompting their lawsuit that concluded May 30. 'It appears that they were providing him some very basic care,' the family's attorney, Madison Cogan, said Friday. 'And by that, I mean they were going into his room, as far as we can tell. But as far as getting dialysis, that never happened, and I think that is what makes this so egregious. All it took is one nurse to recognize that Sandy needed his dialysis and that he wasn't receiving it.' A jury agreed, holding Landmark and its management company, Infinity Healthcare Management of Illinois LLC, accountable for $5.5 million in damages for neglecting Brooks, whose need for dialysis was chronicled by the hospital where he was previously treated. Landmark of Richton Park did not return messages requesting comment. Cogan said the family had sought between $6 million and $8 million. 'It's really hard to put a number on a life,' she said. Andrea said nothing has been the same since she lost her dad. 'This case, it made me relive everything,' she said. 'I could not believe the magnitude of how my dad suffered, and it just hurt me. It broke my heart that someone could just not care or not do their job.'
Yahoo
7 hours ago
- Yahoo
Viking Therapeutics (VKTX) Rises on Expected Developments
We recently published a list of . In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other top-performing companies on Tuesday. Viking Therapeutics grew its share prices by 5.69 percent on Tuesday to finish at $29.14 apiece as investors loaded up positions while waiting for fresh catalysts from the series of global conferences that it is participating in this month. At present, investors are expecting updates and developments from the three-day 46th Annual Goldman Sachs Global Healthcare Conference in Florida on June 9 to 11. It is also set to participate in a one-on-one meeting at the Scotiabank Third Annual Healthcare Canadian Investor Day on June 17. In April this year, Viking Therapeutics, Inc. (NASDAQ:VKTX) soared following news that its competitor, Pfizer Inc., discontinued the development of its oral obesity medication, danuglipron, amid safety concerns. According to PFE, the decision came after a patient experienced a potential liver injury linked to the drug. A microbiologist in protective gear studying samples in a laboratory. The scrapped plans, however, spelled good news for Viking Therapeutics, Inc. (NASDAQ:VKTX), which is similarly underway with the development of an oral weight loss candidate called VK2735, with Pfizer Inc. now out of the competition. Overall, VKTX ranks 8th on our list of top-performing companies on Tuesday. While we acknowledge the potential of VKTX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
